<< Laxai Pharma reports $1,735K revenue for first six months | Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский

Sonomax Technologies 2010 second quarter revenue increases to $328,980

Published on August 26, 2010 at 11:08 PM · No Comments

Sonomax Technologies Inc. ("Sonomax" or the "Company") (TSX Venture: SHH) today disclosed its results for the three and six month periods ended June 30, 2010.

As Sonomax continues work towards becoming an R&D licensing company,Second Quarter 2010 highlights were: Increase in net revenue to $328,980 in 2010 from $70,596 in 2009. - Gross profit was $87,089 in 2010 compared to $6,707 in 2009. - Increase in operating expenses to $415,899 compared to $343,300 in 2009

Source: SONOMAX TECHNOLOGIES INC.

Posted in:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading